Contact Us
Migraine headaches are far more than severe headaches. They are a complex neurological condition involving changes in brain activity, sensory processing, and neural connectivity that can significantly affect daily life.
For many people, migraine symptoms interfere with work, sleep, concentration, and emotional well-being. While medications can help some individuals, others continue to experience chronic migraines, medication side effects, or incomplete symptom relief despite trying multiple treatments.
At Neurotherapeutix, personalized fMRI-guided TMS therapy offers a non-invasive approach designed to target the neural circuits involved in migraine activity. Using advanced imaging and fMRI-guided computational brain mapping, clinicians evaluate how different brain networks communicate and develop treatment strategies tailored to each patient’s connectivity patterns.
If you are looking for a migraine specialist in NYC or exploring alternatives to traditional migraine therapies, Neurotherapeutix provides precision-guided care focused on long-term neurological health and symptom management.
To learn more about migraine TMS therapy or schedule an evaluation, contact our team or continue reading.
Migraine headaches are a neurological disorder involving abnormal brain activity, sensory processing changes, and disrupted communication between neural networks.
According to the American Migraine Foundation, migraines affect more than one billion people worldwide and are one of the leading causes of disability globally.
Unlike tension headaches, migraines often involve multiple neurological symptoms beyond head pain alone. Episodes may last for hours or even days and can significantly affect concentration, vision, movement, and sensitivity to environmental stimuli.
For some individuals, migraines occur occasionally. For others, they become chronic and interfere with nearly every aspect of daily life.
Migraines can affect multiple brain systems simultaneously.
Symptoms may include:
Some individuals also experience warning signs before a migraine begins, including mood changes, food cravings, fatigue, or sensory disturbances.
Because migraines involve neurological dysfunction rather than pain alone, treatment often requires more than standard headache management strategies.
Tension headaches are generally associated with muscle tension and mild to moderate pain. Migraines involve more complex neurological changes.
Migraine episodes are often linked to abnormal sensory processing, cortical excitability, and altered communication between brain regions involved in pain regulation and emotional processing.
This distinction is important because migraine-focused therapies may need to address disrupted neural connectivity rather than focusing solely on symptoms.
Research increasingly shows that migraines are associated with disruptions in functional brain connectivity.
Rather than involving a single isolated brain region, migraines appear to affect multiple interacting neural networks responsible for sensory processing, pain regulation, emotional response, and cognitive control.
Functional imaging studies have identified altered activity involving:
This network-based understanding helps explain why migraines can involve symptoms far beyond head pain alone.
In migraine patients, communication between neural networks may become dysregulated.
Some regions may become hyperactive, while others may struggle to appropriately regulate sensory information. This imbalance may contribute to:
Because migraines involve changes in network communication, therapies that target neural connectivity may help support more adaptive brain function over time.
This is one reason personalized TMS approaches have become a growing area of interest in migraine treatment research.
Transcranial magnetic stimulation uses magnetic pulses to influence activity within targeted brain regions and neural networks.
According to the U.S. Food and Drug Administration, certain TMS devices have received FDA clearance for migraine treatment, including single-pulse TMS devices developed for migraine with aura.
Research into repetitive TMS for migraines has also expanded significantly in recent years, particularly in patients with chronic or treatment-resistant symptoms.address the neurological root of migraine, not just the symptoms.
Clinical studies suggest TMS may help reduce migraine frequency, symptom severity, and migraine-related disability in some patients.
Research has explored how stimulation may influence:
Some studies suggest repeated stimulation may help normalize abnormal connectivity patterns associated with chronic migraine activity.
At Neurotherapeutix, clinicians build upon this research using individualized targeting informed by functional connectivity analysis rather than generalized anatomical positioning.
This allows treatment to focus on the specific neural circuits associated with each patient’s symptoms.ent where it is most needed.
It is important to understand that TMS protocols for migraines may vary depending on the patient’s condition, symptom profile, and treatment goals.
While certain TMS devices have FDA clearance for migraine-related applications, Neurotherapeutix uses a personalized, fMRI-guided approach designed around each patient’s unique brain connectivity patterns.
Rather than applying a generalized protocol, clinicians use imaging and computational analysis to evaluate which neural networks may be contributing to symptoms and how targeted stimulation may help support healthier communication across those circuits.
One of the defining differences at Neurotherapeutix is the use of advanced imaging to personalize treatment planning.
At Neurotherapeutix, clinicians use advanced computational brain mapping and resting-state fMRI (rsfMRI) to evaluate how neural networks communicate and interact at rest.
Resting-state functional MRI measures blood oxygen level-dependent (BOLD) signals across neural networks to identify disrupted connectivity patterns.
In migraine patients, imaging may reveal abnormalities involving:
This information becomes the basis for computational analysis and personalized targeting.
Rather than assuming the same treatment target works for every migraine patient, clinicians can tailor stimulation to the networks most closely associated with that individual’s symptoms.
TMS therapy may be appropriate for individuals experiencing chronic migraines, medication intolerance, or inadequate symptom control with traditional therapies.
Some patients pursue fMRI-guided TMS therapy after years of trying different medications with limited success. Others are looking for a non-invasive treatment option that does not rely solely on ongoing medication use.
Candidates may include individuals who:
Some individuals with related neurological conditions or chronic pain symptoms treated with TMS therapy may also benefit from further evaluation.
Not every patient is an ideal candidate for fMRI-guided TMS therapy.
Certain implanted medical devices, seizure-related considerations, or other neurological factors may affect treatment eligibility. This is why comprehensive evaluation and imaging review are important before beginning therapy.
At Neurotherapeutix, treatment planning is individualized based on each patient’s medical history, symptoms, and connectivity analysis.
TMS therapy is non-invasive and does not require anesthesia or sedation.
During treatment, a neuronavigational guidance system displays the patient’s own brain while they are seated in the treatment chair.
Using this guidance, the magnetic coil is precisely aligned with the personalized target identified through computational analysis, and magnetic pulses are delivered directly to the selected neural circuits.
Patients remain awake throughout the session and typically return to normal daily activities afterward.
Individuals interested in learning more about the treatment process can learn more about how TMS therapy works.
Most patients tolerate TMS therapy well.
Possible minor side effects may include:
Serious side effects are uncommon when treatment is performed according to established clinical protocols.
Because Neurotherapeutix uses individualized targeting and precision-guided treatment planning, our clinicians can closely monitor response and adjust treatment as needed.
Treatment schedules vary depending on the individual patient and treatment goals.
Many patients complete multiple sessions over several weeks, allowing repeated stimulation to support gradual neuroplastic changes across targeted networks.
Because neuroplasticity develops over time, improvement may occur progressively rather than immediately after a single session.
Migraine symptoms can affect more than physical comfort alone. Chronic migraines may also influence stress levels, mood regulation, sleep quality, concentration, and emotional well-being.
At Neurotherapeutix, migraine care may be integrated with other supportive services when appropriate, including full psychiatric services and neurological evaluation.
The goal is to support long-term brain health and individualized care rather than focusing only on symptom suppression.
Yes, TMS therapy may help reduce migraine frequency, severity, and symptom burden in some individuals. Outcomes vary between patients, which is why individualized evaluation and targeting are important.
Treatment schedules vary based on symptom severity, treatment response, and individualized planning. Many patients complete a series of sessions over several weeks.
TMS therapy is considered non-invasive and generally well-tolerated when performed according to established clinical protocols. Most side effects are mild and temporary.
Possibly. Some patients pursue TMS therapy because medications have not provided adequate relief or have caused side effects. Treatment decisions should always be discussed with a qualified clinician based on individual medical needs.
Standard TMS often relies on generalized anatomical positioning. At Neurotherapeutix, personalized TMS, compared with standard approaches, uses advanced functional connectivity analysis and data‑driven brain mapping to identify personalized treatment targets based on each patient’s unique network communication patterns.
Migraines are a neurological condition involving complex changes in brain connectivity, sensory processing, and neural communication.
At Neurotherapeutix, personalized migraine treatment combines advanced imaging, computational analysis, and fMRI-guided TMS therapy to better understand and target the neural circuits involved in symptoms.
By using computational brain mapping, clinicians can develop individualized treatment strategies designed around how each patient’s brain functions in real time.
To learn more about migraine TMS therapy or schedule a consultation, please get in touch with us today.
Call us at (917) 388-3090 or click to request a regular or telehealth appointment.
Neurotherapeutix
171 East 74th Street, Unit 1-1 New York, NY 10021
Neurotherapeutix is the leading clinic for functional imaging guided transcranial magnetic stimulation (TMS), a safe, innovative, and non-invasive methodology for treating a wide range of acute and chronic mental disorders and brain injuries. Our advanced fMRI technology allows us to map the brain for the… Learn More »
By: Neurotherapeutix NYC
Reviewed By: Marta Moreno, Ph.D
Published: March 24, 2023
Last Reviewed: March 5, 2026
QUICK INQUIRY
Contact us to get an estimate for your medical services requirements. You can fill in the form to specify your medical requirements or you can call us directly.